Barclays Begins Coverage on Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)

Stock analysts at Barclays initiated coverage on shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) in a note issued to investors on Wednesday, Briefing.com reports. The firm set an “equal weight” rating and a $10.00 price target on the stock. Barclays‘s target price points to a potential upside of 0.40% from the stock’s previous close.

A number of other research firms have also recently weighed in on SENS. Mizuho dropped their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Weiss Ratings raised shares of Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, September 17th. Finally, Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

Shares of NASDAQ SENS opened at $9.96 on Wednesday. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62. The firm’s 50-day moving average price is $8.65 and its two-hundred day moving average price is $7.06. Senseonics Holdings, Inc. Common Stock has a 52-week low of $4.79 and a 52-week high of $10.64. The stock has a market capitalization of $416.33 million, a P/E ratio of -4.47 and a beta of 1.02.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its earnings results on Thursday, August 6th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The company had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. As a group, sell-side analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current year.

Insider Buying and Selling at Senseonics Holdings, Inc. Common Stock

In related news, Director Douglas Roeder acquired 13,953 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Wednesday, August 19th. The stock was acquired at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares of the company’s stock, valued at $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

A number of hedge funds and other institutional investors have recently made changes to their positions in SENS. BlackRock Inc. bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $15,867,000. Masters Capital Management LLC lifted its position in Senseonics Holdings, Inc. Common Stock by 100.0% in the first quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock worth $3,330,000 after purchasing an additional 250,002 shares during the period. Bank of America Corp DE acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter worth approximately $2,241,000. Readystate Asset Management LP bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth $574,000. Finally, Penn Capital Management Company LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth $535,000. 12.36% of the stock is currently owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes. Its products are designed to measure glucose levels continuously and provide data through a wearable transmitter and mobile application, supporting diabetes management and treatment decisions.

The company’s primary product is the Eversense CGM system, which uses a small sensor implanted under the skin and a removable, rechargeable transmitter worn over the sensor.